# Research Idea Ranking

**Generated:** 2026-01-22T14:12:35.159584
**Model:** gpt-5.2 (reasoning: high)
**Tokens:** 6080
**OpenAI Response ID:** resp_056c6dd3cd81fdf700697222042d208196a8e87b74b9a33487

---

### Rankings

**#1: Aging Out of Parental Insurance at 26 and Fertility Decisions**
- **Score: 66/100**
- **Strengths:** Clear, plausibly exogenous age-based discontinuity with enormous ACS sample sizes; outcome (birth in last 12 months) is directly observed and policy-relevant for understanding how insurance affects fertility timing. The “age-26” setting is well-understood, which helps credibility and benchmarking.
- **Concerns:** The ACS running variable is **age-in-years** (mass points), and the dependent-coverage “loss” is **not truly instantaneous at the 26th birthday** (often end-of-month/plan-year), making this closer to a **fuzzy/discrete RDD** than a sharp RDD. FER (“birth in past 12 months”) blurs timing (conceptions pre-date age 26), so any effect is mechanically attenuated and could be hard to interpret as a timing vs. level effect.
- **Novelty Assessment:** **Medium.** ACA dependent coverage at 26 is heavily studied for insurance/health/labor outcomes; fertility specifically is less saturated, and an RDD on fertility is more novel than the typical DiD age-group comparison, but this won’t be seen as a “new policy.”
- **Recommendation:** **PURSUE (conditional on: using methods for discrete/mass-point running variables; explicitly modeling fuzziness around birthday/plan-year; presenting strong balance/placebo tests at nearby ages and by sex)**

---

**#2: ACA Age 26 with State Variation in Pre-ACA Dependent Coverage Laws (Difference-in-Discontinuities)**
- **Score: 58/100**
- **Strengths:** Conceptually strong: a difference-in-discontinuities can help separate “general age-26 changes” from the insurance mechanism and can be persuasive if executed cleanly. High upside if it convincingly shows that the discontinuity appears/strengthens exactly when/where eligibility changes.
- **Concerns:** As written (ACS **2008–2022**), you have **≤2 pre-treatment years**, which is a **pre-trends dealbreaker** for any DiD-style claim. Also, “pre-ACA dependent coverage laws” differ materially (eligibility conditions like student status, unmarried status, residency, fully-insured vs self-insured ERISA plans), creating real risk that “treated vs control” is not comparable and that the first stage (coverage shift at 26) varies unpredictably across states.
- **Novelty Assessment:** **Medium-High.** Difference-in-discontinuities for ACA age-26 is less common than standard approaches, and applying it to fertility is relatively novel; still, the underlying policy setting is well-trodden.
- **DiD Assessment (Checklist):**
  - **Pre-treatment periods:** **Weak** *(with 2008–2009 only, you cannot credibly test parallel trends; fixable only by extending earlier ACS years and showing stable pre-patterns in discontinuities)*  
  - **Selection into treatment:** **Strong** *(ACA mandate is external; however, classification by pre-ACA state laws introduces heterogeneity—doesn’t kill it, but complicates interpretation)*  
  - **Comparison group:** **Marginal** *(states with pre-ACA laws may differ systematically; requires careful re-weighting/stratification and first-stage validation)*  
  - **Treatment clusters:** **Strong** *(many states effectively “newly treated” by ACA; clustering at state level feasible)*  
  - **Concurrent policies:** **Marginal** *(ACA had many components, but the virtue of the discontinuity is that most other components do not change discretely at 26; still, time-varying state policies and Medicaid expansion later need handling)*  
  - **Outcome-Policy Alignment:** **Strong** *(FER is a direct fertility/birth measure; mechanism is plausible though timing attenuation remains)*
- **Recommendation:** **CONSIDER (conditional on: expanding pre-period to ≥5 years; documenting/state-by-state first-stage effects on insurance at 26; narrowing to years before major later ACA components if needed, e.g., 2005–2013)**  
  *(As proposed with only 2 pre-years, it is not DiD-credible.)*

---

**#3: Title X Income Threshold and Contraceptive Access (Fuzzy RDD at 100% FPL / 250% FPL)**
- **Score: 42/100**
- **Strengths:** High conceptual novelty—an income-threshold design for Title X is not the standard approach, and the policy question (subsidized contraception → fertility) is important. POVPIP is continuous and measured for a very large sample.
- **Concerns:** The design likely fails on **first-stage/threshold realism**: Title X access is not a clean national entitlement with enforcement at exactly 100% FPL; clinics have discretion, capacity constraints, local funding environments, and individuals can access other subsidized contraception channels. ACS cannot identify Title X use, so you cannot verify compliance/eligibility take-up, and income around 100% FPL is prone to **measurement error/heaping**, undermining any discontinuity.
- **Novelty Assessment:** **High** (but high novelty here is mostly because the identifying variation is probably too weak to have been used—not because it’s a hidden gem).
- **Recommendation:** **SKIP (unless you can link to administrative/clinic data that measures actual Title X receipt and enforceable eligibility rules locally)**

---

**#4: State IVF Insurance Mandate Age Limits (NJ/RI)**
- **Score: 23/100**
- **Strengths:** The age cutoffs are policy-defined and, in principle, create a very compelling sharp design; the question is policy-relevant given ongoing debates about infertility coverage.
- **Concerns:** **Data feasibility is the blocker.** Public CDC NASS ART data are not set up for individual-level RDD at exact ages; sample sizes in specific mandate states near the cutoff are likely small, and without restricted microdata you can’t implement the design credibly.
- **Novelty Assessment:** **High** (age-limit RDD angle is genuinely less studied than “IVF mandate vs no mandate”), but it’s high because the usable data are hard to obtain.
- **Recommendation:** **SKIP (unless you can secure restricted individual-cycle data with exact age and state/insurer coverage identifiers)**

---

**#5: Medicare Eligibility at 65 and Fertility Treatment Coverage**
- **Score: 3/100**
- **Strengths:** None for the stated outcome/policy link.
- **Concerns:** Outcome-policy mismatch: Medicare eligibility is largely irrelevant for fertility treatment decisions at 65, and Medicare does not meaningfully cover fertility services in a way that would create a plausible discontinuity in those outcomes.
- **Novelty Assessment:** Not meaningfully novel; it’s essentially not a coherent policy evaluation question.
- **Recommendation:** **SKIP**

---

### Summary

This is a mixed batch: one clearly feasible and reasonably credible project (**Idea 1**) and one higher-upside design (**Idea 5**) that is **not DiD-credible as currently scoped** due to insufficient pre-periods (fixable by expanding earlier ACS years and validating first-stage variation). The Title X threshold idea is novel but likely fails on real-world threshold enforcement and lack of treatment measurement in ACS, while the IVF age-limit RDD is attractive in theory but blocked by data access.